Innova Captab Limited
INNOVACAP.NS - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$56.5B
Close$
$-831.11
179.2% downside
Current Fair Value
179.2% downsideOvervalued by 179.2% based on the discounted cash flow analysis.
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $56.50 Billion |
|---|---|
| Enterprise Value | $56.50 Billion |
| Annual dividend | $2.00 |
| Dividend yield | 0.20% |
| Earnings per Share | $24.63 |
| Beta | -0.05 |
| Outstanding Shares | 57,224,929 |
Return
| Return on Equity | 14.12% |
|---|---|
| Return on Assets | NaN% |
| Return on Invested Capital | NaN% |
Valuation & Multiples
| P/E Ratio | 36.69 |
|---|---|
| PEG | 86.79 |
| Price to Sales | 3.44 |
| Price to Book Ratio | 5.52 |
| Enterprise Value to Revenue | 3.23 |
| Enterprise Value to EBIT | 25.56 |
| Enterprise Value to Net Income | 36 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0 |
Revenue Sources
No data
Last Earnings Call
Report Date
August 11, 2026
EPS Estimate
$3.43
Consensus analyst estimateRevenue Estimate
$4.52 B
Consensus analyst estimateNext Earnings Call
Expected Date
November 6, 2026
EPS Estimate
$8.00
Consensus analyst estimateRevenue Estimate
$4.89 B
Consensus analyst estimateInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
About Innova Captab Limited
1,600 employees
CEO: Vinay Lohariwala
Innova Captab Limited, established in Panchkula, India, in 2005, operates as a comprehensive pharmaceutical enterprise. Its operations encompass the full spectrum of drug development, from research and development and manufacturing to di...